Acasti Announces Fourth Quarter and Fiscal Year Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Neptune Technologies (NEPT) Misses Q4 EPS by 8c
May 28, 2015 6:23 AM EDTNeptune Technologies (NASDAQ: NEPT) reported Q4 EPS of ($0.12), $0.08 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $4.02 million versus the consensus estimate of $5.6 million.
For earnings history and earnings-related data on Neptune Technologies (NEPT) click here.
... MoreAcasti Pharma (ACST) Reports Q4 Loss of $0.02
May 27, 2015 5:43 PM EDTAcasti Pharma (NASDAQ: ACST) reported Q4 EPS of ($0.02), versus ($0.02) reported last year.
Acasti is now corresponding with the FDA to determine next steps in the clinical development of CaPre®, and obtain the required authorizations to proceed with such steps, including initiating a Phase... More
